Item Type | Name |
Concept
|
Aged
|
Concept
|
Aged, 80 and over
|
Concept
|
Middle Aged
|
Academic Article
|
Clinical decisions in idiopathic thrombocytopenic purpura.
|
Academic Article
|
ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.
|
Academic Article
|
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
|
Academic Article
|
Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care.
|
Academic Article
|
Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.
|
Academic Article
|
A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery.
|
Academic Article
|
Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q).
|
Academic Article
|
Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
|
Academic Article
|
Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.
|
Academic Article
|
Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trial.
|
Academic Article
|
Oral rivaroxaban for symptomatic venous thromboembolism.
|
Academic Article
|
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
|
Academic Article
|
Apixaban for extended treatment of venous thromboembolism.
|
Academic Article
|
The design and implementation of a new surveillance system for venous thromboembolism using combined active and passive methods.
|
Academic Article
|
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
|
Academic Article
|
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
|
Academic Article
|
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
|
Academic Article
|
Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients.
|
Academic Article
|
Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
|
Academic Article
|
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials.
|
Academic Article
|
Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.
|
Academic Article
|
Pharmacokinetics and dynamics of heparin in patients with proximal vein thrombosis.
|
Academic Article
|
A new noninvasive management strategy for patients with suspected pulmonary embolism.
|
Academic Article
|
The low-probability lung scan. A need for change in nomenclature.
|
Academic Article
|
Effect of treatment with low-dose warfarin-aspirin on activated factor VII.
|
Academic Article
|
Cost effectiveness of diagnosis of deep vein thrombosis in symptomatic patients.
|
Academic Article
|
The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis.
|
Academic Article
|
Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement.
|
Academic Article
|
Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer.
|
Academic Article
|
Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harms.
|
Academic Article
|
Idraparinux versus standard therapy for venous thromboembolic disease.
|
Academic Article
|
Extended prophylaxis of venous thromboembolism with idraparinux.
|
Academic Article
|
The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
|
Academic Article
|
Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
|
Academic Article
|
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.
|
Academic Article
|
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials.
|
Academic Article
|
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
|
Academic Article
|
Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups.
|
Academic Article
|
Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
|
Academic Article
|
Factor XI antisense oligonucleotide for prevention of venous thrombosis.
|
Academic Article
|
Global public awareness of venous thromboembolism.
|
Academic Article
|
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.
|
Academic Article
|
The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
|
Academic Article
|
Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.
|
Academic Article
|
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.
|
Academic Article
|
Extended vs. standard-duration thromboprophylaxis in acutely ill medical patients: A systematic review and meta-analysis.
|
Academic Article
|
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study.
|
Academic Article
|
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients.
|
Academic Article
|
Incidence of Venous Thromboembolism in a Racially Diverse Population of Oklahoma County, Oklahoma.
|
Academic Article
|
A cost-effectiveness analysis of alternative approaches for long-term treatment of proximal venous thrombosis.
|
Academic Article
|
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.
|
Academic Article
|
Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Coumadin Aspirin Reinfarction (CARS) Pilot Study Group.
|
Academic Article
|
Aging and heparin-related bleeding.
|
Academic Article
|
Monitoring low-dose warfarin therapy by a central laboratory and implications for clinical trials and patient care. The Coumadin Aspirin Reinfarction (CARS) Pilot Study Group.
|
Academic Article
|
Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
|
Academic Article
|
Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group.
|
Academic Article
|
Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: clinical implications of the site of vein noncompressibility.
|
Academic Article
|
Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings.
|
Academic Article
|
Exclusion of first-episode deep-vein thrombosis after-hours using D-dimer.
|
Academic Article
|
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.
|
Academic Article
|
Pulmonary embolism in outpatients with pleuritic chest pain.
|
Academic Article
|
Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome.
|
Academic Article
|
Apixaban or enoxaparin for thromboprophylaxis after knee replacement.
|
Academic Article
|
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.
|
Academic Article
|
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.
|
Academic Article
|
Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
|
Academic Article
|
Oral apixaban for the treatment of acute venous thromboembolism.
|
Academic Article
|
Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan.
|
Academic Article
|
Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism. An analysis of the randomised, double-blind HOKUSAI VTE trial.
|
Academic Article
|
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.
|
Academic Article
|
Physician-guided treatment compared with a heparin protocol for deep vein thrombosis.
|
Academic Article
|
A noninvasive strategy for the treatment of patients with suspected pulmonary embolism.
|
Academic Article
|
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
|
Academic Article
|
Underuse of venous thromboembolism prophylaxis for general surgery patients: physician practices in the community hospital setting.
|
Academic Article
|
Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg tests.
|
Academic Article
|
Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
|
Academic Article
|
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.
|
Academic Article
|
A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
|
Academic Article
|
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
|
Academic Article
|
The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.
|
Academic Article
|
Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy. A sub-analysis of the AMPLIFY trial.
|
Academic Article
|
Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.
|
Academic Article
|
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis.
|
Academic Article
|
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study.
|
Academic Article
|
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
|
Academic Article
|
Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial.
|
Academic Article
|
The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients.
|
Academic Article
|
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
|
Academic Article
|
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists.
|
Academic Article
|
Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial.
|
Academic Article
|
Randomized phase 2 trial comparing JNJ-9375, a thrombin-directed antibody, with apixaban for prevention of venous thrombosis.
|
Academic Article
|
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.
|
Academic Article
|
Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement.
|
Academic Article
|
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.
|
Academic Article
|
Clinical validity of a normal perfusion lung scan in patients with suspected pulmonary embolism.
|
Academic Article
|
Predicting the daily prothrombin time response to warfarin.
|
Academic Article
|
Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism.
|
Academic Article
|
A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
|
Academic Article
|
Duplex ultrasonography for the detection of deep vein thrombi after total hip or knee arthroplasty.
|
Academic Article
|
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients.
|
Academic Article
|
Milvexian for the Prevention of Venous Thromboembolism.
|
Academic Article
|
Abelacimab for Prevention of Venous Thromboembolism.
|
Academic Article
|
Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older.
|
Academic Article
|
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
|